Stacey Rogers, M.D., FACOG
Specialties
Gynecologic Oncology
Primary Location
Chesapeake
744 N Battlefield Blvd
Chesapeake, VA 23320
Main Phone:
(757) 549-4403
Medical School
University of Vermont College of Medicine
Internship
Naval Hospital, San Diego
Residency
Naval Hospital, San Diego | Obstetrics and Gynecology
Fellowship
Walter Reed Army Medical Center | Gynecologic Oncology
Board Certification
- Obstetrics/Gynecology
- Gynecologic Oncology
- Hospice and Palliative Medicine
Biography
Dr. Rogers is board-certified in Gynecologic Oncology and Obstetrics and Gynecology. She has advanced the practice of gynecologic cancer medicine at Virginia Oncology Associates (VOA) since 2004. With extensive experience in advanced surgical care, Dr. Rogers emphasizes precision, sound clinical judgment, and minimally invasive surgical techniques when appropriate. She is committed to developing individualized treatment plans that support excellent patient outcomes. Prior to joining VOA, she served as Staff Gynecologic Oncologist and Gynecologic Oncology Division Director at the Naval Medical Center Portsmouth in Portsmouth, Virginia.
Dr. Rogers received a master’s in nutrition from New York City’s prestigious Columbia University. She earned her Doctor of Medicine degree from the University of Vermont College of Medicine in Burlington, Vermont. Her internship and residency were completed at Naval Hospital San Diego in San Diego, California. She then completed her Gynecologic Oncology Fellowship at Walter Reed Army Medical Center in Washington, DC.
Dr. Rogers is a strong advocate for academics and research. Her work on leiomyosarcoma, stage distribution of cervical cancer, and other topics has been presented at the American College of Obstetricians and Gynecologists Armed Forces District annual meetings and published in journals including Cancer and Gynecologic Oncology. Dr. Rogers remains actively involved in research through ongoing projects exploring pathways in ovarian cancer cell lines and the role of Vitamin B Complex in the treatment of chemotherapy-induced peripheral neuropathy, among other areas of study.